TrialAddiction (Abingdon, England)2017

Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.

Sean M Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.